Shengliang Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shengliang Peng has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Haijun Hu
Department of Anesthesiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University
2 shared publicationsXiaohong Du
Department of Anesthesiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University
2 shared publicationsZiyan Hu
Department of Anesthesiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University
2 shared publicationsBin Hu
Department of Emergency Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China
1 shared publicationCheng Chen
Department of Anesthesiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University
1 shared publicationDan Huang
Department of Anesthesiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University
1 shared publication
Latest Publications
- Open Access
- 28 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1817855
Artificial intelligence in anesthesiology education: transformative applications, challenges, and future perspectives
Artificial intelligence offers the potential to revolutionize anesthesiology education by enabling precision education, a data-driven approach to tailor learning experiences to individual needs, thereby moving beyond the constraints of traditional pedagogical methods. This review examines the emerging applications and potential impact of AI-driven technologies, from virtual reality simulators that facilitate deliberate practice of complex procedures to machine learning platforms that enable precision education and objective competency assessment. We highlight how these tools enhance procedural fluency, clinical reasoning, and educational management. Nevertheless, this technological advancement is accompanied by profound challenges, including the risks of de-skilling, the perpetuation of algorithmic biases, data security vulnerabilities, and issues of equitable access. We argue that AI’s role is as an augmentative tool, empowering educators to provide more personalized feedback and facilitate higher-order skill development, while also raising crucial ethical considerations. Navigating the future of anesthesiology education requires a balanced approach: embracing the benefits of AI while implementing robust governance to mitigate its risks, thereby fostering a new generation of anesthesiologists equipped to leverage technology for superior patient care. To this end, future research should prioritize rigorous validation of AI tools in clinical settings and focus on ethical guidelines for responsible AI implementation.
- 28 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1817855
Open AccessArtificial intelligence in anesthesiology education: transformative applications, challenges, and future perspectives
Artificial intelligence offers the potential to revolutionize anesthesiology education by enabling precision education, a data-driven approach to tailor learning experiences to individual needs, thereby moving beyond the constraints of traditional pedagogical methods. This review examines the emerging applications and potential impact of AI-driven technologies, from virtual reality simulators that facilitate deliberate practice of complex procedures to machine learning platforms that enable precision education and objective competency assessment. We highlight how these tools enhance procedural fluency, clinical reasoning, and educational management. Nevertheless, this technological advancement is accompanied by profound challenges, including the risks of de-skilling, the perpetuation of algorithmic biases, data security vulnerabilities, and issues of equitable access. We argue that AI’s role is as an augmentative tool, empowering educators to provide more personalized feedback and facilitate higher-order skill development, while also raising crucial ethical considerations. Navigating the future of anesthesiology education requires a balanced approach: embracing the benefits of AI while implementing robust governance to mitigate its risks, thereby fostering a new generation of anesthesiologists equipped to leverage technology for superior patient care. To this end, future research should prioritize rigorous validation of AI tools in clinical settings and focus on ethical guidelines for responsible AI implementation.
- 18 September 2024
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 40 (6) , e3841
Progress in the Pathogenesis of Diabetic Encephalopathy: The Key Role of Neuroinflammation
Diabetic encephalopathy (DE) is a severe complication that occurs in the central nervous system (CNS) and leads to cognitive impairment. DE involves various pathophysiological processes, and its pathogenesis is still unclear. This review summarised current research on the pathogenesis of diabetic encephalopathy, which involves neuroinflammation, oxidative stress, iron homoeostasis, blood‐brain barrier disruption, altered gut microbiota, insulin resistance, etc. Among these pathological mechanisms, neuroinflammation has been focused on. This paper summarises some of the molecular mechanisms involved in neuroinflammation, including the Mammalian Target of Rapamycin (mTOR), Lipocalin‐2 (LCN‐2), Pyroptosis, Advanced Glycosylation End Products (AGEs), and some common pro‐inflammatory factors. In addition, we discuss recent advances in the study of potential therapeutic targets for the treatment of DE against neuroinflammation. The current research on the pathogenesis of DE is progressing slowly, and more research is needed in the future. Further study of neuroinflammation as a mechanism is conducive to the discovery of more effective treatments for DE in the future.
- 18 September 2024
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 40 (6) , e3841
Progress in the Pathogenesis of Diabetic Encephalopathy: The Key Role of Neuroinflammation
Diabetic encephalopathy (DE) is a severe complication that occurs in the central nervous system (CNS) and leads to cognitive impairment. DE involves various pathophysiological processes, and its pathogenesis is still unclear. This review summarised current research on the pathogenesis of diabetic encephalopathy, which involves neuroinflammation, oxidative stress, iron homoeostasis, blood‐brain barrier disruption, altered gut microbiota, insulin resistance, etc. Among these pathological mechanisms, neuroinflammation has been focused on. This paper summarises some of the molecular mechanisms involved in neuroinflammation, including the Mammalian Target of Rapamycin (mTOR), Lipocalin‐2 (LCN‐2), Pyroptosis, Advanced Glycosylation End Products (AGEs), and some common pro‐inflammatory factors. In addition, we discuss recent advances in the study of potential therapeutic targets for the treatment of DE against neuroinflammation. The current research on the pathogenesis of DE is progressing slowly, and more research is needed in the future. Further study of neuroinflammation as a mechanism is conducive to the discovery of more effective treatments for DE in the future.
- Open Access
- 2 November 2023
- Published by Springer Nature in Translational Neurodegeneration
- Vol. 12 (1) , 1-16
NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors
Cognitive impairment is a multifactorial and multi-step pathological process that places a heavy burden on patients and the society. Neuroinflammation is one of the main factors leading to cognitive impairment. The inflammasomes are multi-protein complexes that respond to various microorganisms and endogenous danger signals, helping to initiate innate protective responses in inflammatory diseases. NLRP3 inflammasomes produce proinflammatory cytokines (interleukin IL-1β and IL-18) by activating caspase-1. In this review, we comprehensively describe the structure and functions of the NLRP3 inflammasome. We also explore the intrinsic relationship between the NLRP3 inflammasome and cognitive impairment, which involves immune cell activation, cell apoptosis, oxidative stress, mitochondrial autophagy, and neuroinflammation. Finally, we describe NLRP3 inflammasome antagonists as targeted therapies to improve cognitive impairment.
- 2 November 2023
- Published by Springer Nature in Translational Neurodegeneration
- Vol. 12 (1) , 1-16
Open AccessNLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors
Cognitive impairment is a multifactorial and multi-step pathological process that places a heavy burden on patients and the society. Neuroinflammation is one of the main factors leading to cognitive impairment. The inflammasomes are multi-protein complexes that respond to various microorganisms and endogenous danger signals, helping to initiate innate protective responses in inflammatory diseases. NLRP3 inflammasomes produce proinflammatory cytokines (interleukin IL-1β and IL-18) by activating caspase-1. In this review, we comprehensively describe the structure and functions of the NLRP3 inflammasome. We also explore the intrinsic relationship between the NLRP3 inflammasome and cognitive impairment, which involves immune cell activation, cell apoptosis, oxidative stress, mitochondrial autophagy, and neuroinflammation. Finally, we describe NLRP3 inflammasome antagonists as targeted therapies to improve cognitive impairment.